Viral Vector Manufacturing Market to Study Capacity, Production, Value, Share and Development Plans in Future by Major Dominated Key Players till 2023

“Viral Vector Manufacturing Market”
Viral Vector Manufacturing Market is expected to register a CAGR Approx. 22.65% with an expected market value of USD 319 million during the forecast period of 2018–2023

Global viral vector manufacturing market is expected to grow significantly over the forecast period. It is projected that the global viral vector manufacturing market is expected to register a CAGR Approx. 22.65% with an expected market value of USD 319 million during the forecast period of 2018–2023.

Gene therapy is one of the preferred treatment options for most chronic diseases, involving insertion of a functional copy of a gene into a defective cell. Viral vector methods are used in effective transfer of therapeutic gene into the target cells. Viral vectors used in gene therapy include retroviral vectors, adenoviral vectors and adeno-associated viral vectors.

Numerous factors such as rise in number of clinical trials, increase in the number of gene therapy candidates, and growing necessity for an effective mode of disease treatment are expected to drive the growth of the market. Also, the characteristics of viral vectors such as ability to express therapeutic genes efficiently, and non-pathogenic nature fuels the growth of the market.

Avail Sample Research Report at https://www.marketresearchfuture.com/sample_request/6890

Key players:

FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Sanofi, Lonza, Merck KGaA, GENERAL ELECTRIC COMPANY, Oxford BioMedica, Spark Therapeutics, Inc., uniQure N.V., FinVector Vision Therapies, Brammer Bio, Cell and Gene Therapy Catapult, Cobra Biologics, REGENXBIO Inc., and Kaneka Eurogentec S.A. are some of the key players in the global viral vector manufacturing market.

Segmentation:

The global viral vector manufacturing market has been segmented into type, disease, application, and end-user.

Global Viral Vector Manufacturing Market, by Type

  • Retroviral Vectors
    • Lentiviral Vectors
    • Gamma-Retroviral Vectors
  • Adenoviral Vectors
  • Adeno-Associated Viral Vectors
  • Other Viral Vectors

Global Viral Vector Manufacturing Market, by Disease

  • Cancer
  • Genetic Disorders
  • Infectious Diseases
  • Others

Global Viral Vector Manufacturing Market, by Application

  • Gene Therapy
  • Vaccinology

Global Viral Vector Manufacturing Market, by End-user

  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Others

Browse Complete Report Details at https://www.marketresearchfuture.com/reports/viral-vector-manufacturing-market-6890

Regional Analysis:

Geographically, the Americas is anticipated to dominate the global viral vector manufacturing market owing to a well-developed healthcare sector and rising prevalence of autoimmune and chronic diseases. According to a study published by Partnership to Fight Chronic Disease (PFCD) in 2016, 191 million people in America had at least 1 chronic disease, whereas 75 million had 2 or more chronic diseases in the year 2015.

Europe is expected to hold the second largest position in the global viral vector manufacturing market. The market growth in this region is attributed to the availability of funds for research and increasing healthcare expenditure. According to the European Commission, in 2016 the total expenditure of the governments of the European Union on health amounted to 7.1% of GDP. Also, according to National Institute of Health Funding (NIHR) in the year 2016, a funding of Euro 928 million was announced for new NIHR Biomedical Research Centres (BRC) and NIHR Clinical Research Facilities (CRF) for 5 years starting from April 2017.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population and continuously developing economies.

On the other hand, the Middle East and Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to the growing government initiatives for the healthcare sector.

Inquire for Discount at https://www.marketresearchfuture.com/check-discount/6890

Intended Audience

  • Pharmaceutical Companies
  • Research and Development (R&D) Companies
  • Private Research institutes
  • Diagnostic Laboratories
  • Government Research Institutes
  • Academic Institutes and Universities

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/viral-vector-manufacturing-market-6890